Guardion Health Sciences Past Earnings Performance
Past criteria checks 0/6
Guardion Health Sciences's earnings have been declining at an average annual rate of -26.2%, while the Personal Products industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 63.3% per year.
Key information
-26.2%
Earnings growth rate
36.4%
EPS growth rate
Personal Products Industry Growth | 8.7% |
Revenue growth rate | 63.3% |
Return on equity | -77.5% |
Net Margin | -187.5% |
Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Guardion Health Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 22 | 11 | -21 | 13 | 0 |
30 Jun 22 | 11 | -22 | 15 | 0 |
31 Mar 22 | 9 | -25 | 14 | 0 |
31 Dec 21 | 7 | -25 | 14 | 0 |
30 Sep 21 | 5 | -14 | 12 | 0 |
30 Jun 21 | 2 | -13 | 10 | 0 |
31 Mar 21 | 2 | -9 | 9 | 0 |
31 Dec 20 | 2 | -9 | 9 | 0 |
30 Sep 20 | 2 | -9 | 9 | 0 |
30 Jun 20 | 2 | -9 | 9 | 0 |
31 Mar 20 | 1 | -12 | 10 | 0 |
31 Dec 19 | 1 | -11 | 9 | 0 |
30 Sep 19 | 1 | -8 | 8 | 0 |
30 Jun 19 | 1 | -8 | 7 | 0 |
31 Mar 19 | 1 | -7 | 5 | 0 |
31 Dec 18 | 1 | -8 | 6 | 0 |
30 Sep 18 | 1 | -9 | 7 | 0 |
30 Jun 18 | 1 | -9 | 7 | 0 |
31 Mar 18 | 1 | -8 | 7 | 0 |
31 Dec 17 | 0 | -6 | 5 | 0 |
30 Sep 17 | 0 | -6 | 4 | 0 |
30 Jun 17 | 0 | -6 | 4 | 0 |
31 Mar 17 | 0 | -6 | 4 | 0 |
31 Dec 16 | 0 | -7 | 4 | 0 |
30 Sep 16 | 0 | -5 | 4 | 0 |
30 Jun 16 | 0 | -6 | 4 | 0 |
Quality Earnings: 0QTA is currently unprofitable.
Growing Profit Margin: 0QTA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0QTA is unprofitable, and losses have increased over the past 5 years at a rate of 26.2% per year.
Accelerating Growth: Unable to compare 0QTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 0QTA is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (9.6%).
Return on Equity
High ROE: 0QTA has a negative Return on Equity (-77.51%), as it is currently unprofitable.